AP -- Shares of Sequenom Inc. fell Tuesday after the company revised data on its SEQureDx Down syndrome test, saying it was not as effective at identifying the condition as previously reported.
AP -- Shares of Sequenom Inc. fell Tuesday after the company revised data on its SEQureDx Down syndrome test, saying it was not as effective at identifying the condition as previously reported.
